IBDEI0MN ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10177,1,4,0)
 ;;=4^E10.618
 ;;^UTILITY(U,$J,358.3,10177,2)
 ;;=^5002614
 ;;^UTILITY(U,$J,358.3,10178,0)
 ;;=E10.630^^39^430^30
 ;;^UTILITY(U,$J,358.3,10178,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10178,1,3,0)
 ;;=3^DM Type 1 w/ Peridontal Disease
 ;;^UTILITY(U,$J,358.3,10178,1,4,0)
 ;;=4^E10.630
 ;;^UTILITY(U,$J,358.3,10178,2)
 ;;=^5002619
 ;;^UTILITY(U,$J,358.3,10179,0)
 ;;=E10.638^^39^430^27
 ;;^UTILITY(U,$J,358.3,10179,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10179,1,3,0)
 ;;=3^DM Type 1 w/ Oth Oral Compl
 ;;^UTILITY(U,$J,358.3,10179,1,4,0)
 ;;=4^E10.638
 ;;^UTILITY(U,$J,358.3,10179,2)
 ;;=^5002620
 ;;^UTILITY(U,$J,358.3,10180,0)
 ;;=E10.641^^39^430^15
 ;;^UTILITY(U,$J,358.3,10180,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10180,1,3,0)
 ;;=3^DM Type 1 w/ Hypoglycemia w/ Coma
 ;;^UTILITY(U,$J,358.3,10180,1,4,0)
 ;;=4^E10.641
 ;;^UTILITY(U,$J,358.3,10180,2)
 ;;=^5002621
 ;;^UTILITY(U,$J,358.3,10181,0)
 ;;=E10.649^^39^430^16
 ;;^UTILITY(U,$J,358.3,10181,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10181,1,3,0)
 ;;=3^DM Type 1 w/ Hypoglycemia w/o Coma
 ;;^UTILITY(U,$J,358.3,10181,1,4,0)
 ;;=4^E10.649
 ;;^UTILITY(U,$J,358.3,10181,2)
 ;;=^5002622
 ;;^UTILITY(U,$J,358.3,10182,0)
 ;;=E10.65^^39^430^14
 ;;^UTILITY(U,$J,358.3,10182,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10182,1,3,0)
 ;;=3^DM Type 1 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,10182,1,4,0)
 ;;=4^E10.65
 ;;^UTILITY(U,$J,358.3,10182,2)
 ;;=^5002623
 ;;^UTILITY(U,$J,358.3,10183,0)
 ;;=E10.69^^39^430^29
 ;;^UTILITY(U,$J,358.3,10183,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10183,1,3,0)
 ;;=3^DM Type 1 w/ Oth Spec Compl
 ;;^UTILITY(U,$J,358.3,10183,1,4,0)
 ;;=4^E10.69
 ;;^UTILITY(U,$J,358.3,10183,2)
 ;;=^5002624
 ;;^UTILITY(U,$J,358.3,10184,0)
 ;;=E10.8^^39^430^33
 ;;^UTILITY(U,$J,358.3,10184,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10184,1,3,0)
 ;;=3^DM Type 1 w/ Unspec Compl
 ;;^UTILITY(U,$J,358.3,10184,1,4,0)
 ;;=4^E10.8
 ;;^UTILITY(U,$J,358.3,10184,2)
 ;;=^5002625
 ;;^UTILITY(U,$J,358.3,10185,0)
 ;;=E10.9^^39^430^34
 ;;^UTILITY(U,$J,358.3,10185,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10185,1,3,0)
 ;;=3^DM Type 1 w/o Compl
 ;;^UTILITY(U,$J,358.3,10185,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,10185,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,10186,0)
 ;;=E10.620^^39^430^5
 ;;^UTILITY(U,$J,358.3,10186,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10186,1,3,0)
 ;;=3^DM Type 1 w/ Diab Dermatitis
 ;;^UTILITY(U,$J,358.3,10186,1,4,0)
 ;;=4^E10.620
 ;;^UTILITY(U,$J,358.3,10186,2)
 ;;=^5002615
 ;;^UTILITY(U,$J,358.3,10187,0)
 ;;=E10.36^^39^430^4
 ;;^UTILITY(U,$J,358.3,10187,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10187,1,3,0)
 ;;=3^DM Type 1 w/ Diab Cataract
 ;;^UTILITY(U,$J,358.3,10187,1,4,0)
 ;;=4^E10.36
 ;;^UTILITY(U,$J,358.3,10187,2)
 ;;=^5002602
 ;;^UTILITY(U,$J,358.3,10188,0)
 ;;=E10.621^^39^430^6
 ;;^UTILITY(U,$J,358.3,10188,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10188,1,3,0)
 ;;=3^DM Type 1 w/ Diab Foot Ulcer
 ;;^UTILITY(U,$J,358.3,10188,1,4,0)
 ;;=4^E10.621
 ;;^UTILITY(U,$J,358.3,10188,2)
 ;;=^5002616
 ;;^UTILITY(U,$J,358.3,10189,0)
 ;;=E10.622^^39^430^28
 ;;^UTILITY(U,$J,358.3,10189,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10189,1,3,0)
 ;;=3^DM Type 1 w/ Oth Skin Ulcer
 ;;^UTILITY(U,$J,358.3,10189,1,4,0)
 ;;=4^E10.622
 ;;^UTILITY(U,$J,358.3,10189,2)
 ;;=^5002617
 ;;^UTILITY(U,$J,358.3,10190,0)
 ;;=E10.51^^39^430^32
